<SEC-DOCUMENT>0001213900-25-079145-index.html : 20250821
<SEC-HEADER>0001213900-25-079145.hdr.sgml : 20250821
<ACCEPTANCE-DATETIME>20250821062137
ACCESSION NUMBER:		0001213900-25-079145
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250818
FILED AS OF DATE:		20250821
DATE AS OF CHANGE:		20250821

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			B Group, Inc.
		CENTRAL INDEX KEY:			0002043476
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			KS
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38302
		FILM NUMBER:		251238313

	BUSINESS ADDRESS:	
		STREET 1:		2900 MCKINNON STREET
		STREET 2:		SUITE 1101
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		469-436-3669 EXT 501

	MAIL ADDRESS:	
		STREET 1:		2900 MCKINNON STREET
		STREET 2:		SUITE 1101
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NRX Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001719406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				822844431
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1201 ORANGE STREET
		STREET 2:		SUITE 600
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801
		BUSINESS PHONE:		484-254-6134

	MAIL ADDRESS:	
		STREET 1:		1201 ORANGE STREET
		STREET 2:		SUITE 600
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Big Rock Partners Acquisition Corp.
		DATE OF NAME CHANGE:	20171012
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>